Merrimack Pharmaceuticals, Inc. (MACK) Social Stream
Merrimack Pharmaceuticals Inc (MACK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Merrimack Pharmaceuticals Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 1 | $4 | $4 | $4 | $4.35 | -8.05% |
Price Target Last Issued January 2, 2019
MACK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MACK as an investment opportunity.
- MACK has a greater number of analysts covering the stock than practically none of all US stocks.
- Merrimack Pharmaceuticals Inc's variance in analysts' estimates is lower than almost 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of MACK is greater than 4.07% of Pharmaceutical Products stocks.
- MACK has a greater average analyst price target than 4.49% of Pharmaceutical Products stocks.
Is MACK a Buy, Hold or Sell? See the POWR Ratings now!